CXCL1 as a novel prognostic biomarker and immune regulator in colon adenocarcinoma
Abstract Introduction Colon Adenocarcinoma (COAD) remains a prominent problem among cancers today. COAD is one of the malignancies with a significant overexpression of CXCL1, an enzyme involved in cellular metabolism. However, the key targets for colon cancer are not yet well understood. As a result...
Na minha lista:
| Principais autores: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer
2026-02-01
|
| Colecção: | Discover Oncology |
| Assuntos: | |
| Acesso em linha: | https://doi.org/10.1007/s12672-026-04522-2 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|